302 related articles for article (PubMed ID: 32896690)
1. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
[TBL] [Abstract][Full Text] [Related]
2. An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema.
Liu J; Qin J; Borodovsky A; Racie T; Castoreno A; Schlegel M; Maier MA; Zimmerman T; Fitzgerald K; Butler J; Akinc A
RNA; 2019 Feb; 25(2):255-263. PubMed ID: 30463937
[TBL] [Abstract][Full Text] [Related]
3. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
5. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
[TBL] [Abstract][Full Text] [Related]
6. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
7. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
Renné T; Nieswandt B; Gailani D
Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
[TBL] [Abstract][Full Text] [Related]
8. Generation of a humanized FXII knock-in mouse-A powerful model system to test novel anti-thrombotic agents.
Beck S; Stegner D; Loroch S; Baig AA; Göb V; Schumbrutzki C; Eilers E; Sickmann A; May F; Nolte MW; Panousis C; Nieswandt B
J Thromb Haemost; 2021 Nov; 19(11):2835-2840. PubMed ID: 34363738
[TBL] [Abstract][Full Text] [Related]
9. Factor XII deficiency is common in domestic cats and associated with two high frequency F12 mutations.
Maruyama H; Brooks MB; Stablein A; Frye A
Gene; 2019 Jul; 706():6-12. PubMed ID: 31022435
[TBL] [Abstract][Full Text] [Related]
10. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.
Stavrou E; Schmaier AH
Thromb Res; 2010 Mar; 125(3):210-5. PubMed ID: 20022081
[TBL] [Abstract][Full Text] [Related]
11. Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding.
Cai TQ; Wu W; Shin MK; Xu Y; Jochnowitz N; Zhou Y; Hoos L; Bentley R; Strapps W; Thankappan A; Metzger JM; Ogletree ML; Tadin-Strapps M; Seiffert DA; Chen Z
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):893-902. PubMed ID: 26192114
[TBL] [Abstract][Full Text] [Related]
12. In vivo roles of factor XII.
Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
[TBL] [Abstract][Full Text] [Related]
13. Model-dependent contributions of FXII and FXI to venous thrombosis in mice.
Grover SP; Olson TM; Cooley BC; Mackman N
J Thromb Haemost; 2020 Nov; 18(11):2899-2909. PubMed ID: 33094904
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
[TBL] [Abstract][Full Text] [Related]
16. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic pathway of coagulation and arterial thrombosis.
Gailani D; Renné T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
[TBL] [Abstract][Full Text] [Related]
18. Factor XII in Hemostasis and Thrombosis: Active Player or (Innocent) Bystander?
Danese E; Montagnana M; Lippi G
Semin Thromb Hemost; 2016 Sep; 42(6):682-8. PubMed ID: 27074440
[TBL] [Abstract][Full Text] [Related]
19. Role of Factor XII in hemostasis and thrombosis: clinical implications.
Renné T; Gailani D
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
[TBL] [Abstract][Full Text] [Related]
20. Coagulation factor XII contributes to hemostasis when activated by soil in wounds.
Juang LJ; Mazinani N; Novakowski SK; Prowse ENP; Haulena M; Gailani D; Lavkulich LM; Kastrup CJ
Blood Adv; 2020 Apr; 4(8):1737-1745. PubMed ID: 32339233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
